A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 17,261 shares of AVNS stock, worth $343,666. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,261
Previous 32,790 47.36%
Holding current value
$343,666
Previous $735,000 53.33%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$17.97 - $22.68 $279,056 - $352,197
-15,529 Reduced 47.36%
17,261 $343,000
Q4 2023

Feb 14, 2024

SELL
$17.64 - $22.99 $380,741 - $496,216
-21,584 Reduced 39.7%
32,790 $735,000
Q3 2023

Nov 13, 2023

BUY
$19.93 - $26.31 $90,003 - $118,815
4,516 Added 9.06%
54,374 $1.1 Million
Q2 2023

Aug 11, 2023

SELL
$22.53 - $30.98 $143,763 - $197,683
-6,381 Reduced 11.35%
49,858 $1.27 Million
Q1 2023

May 12, 2023

BUY
$26.92 - $31.75 $53,140 - $62,674
1,974 Added 3.64%
56,239 $1.67 Million
Q4 2022

Feb 13, 2023

SELL
$19.88 - $27.37 $370,523 - $510,122
-18,638 Reduced 25.57%
54,265 $1.47 Million
Q3 2022

Nov 10, 2022

SELL
$21.56 - $29.59 $28,157 - $38,644
-1,306 Reduced 1.76%
72,903 $1.59 Million
Q2 2022

Aug 11, 2022

BUY
$24.87 - $34.68 $165,136 - $230,275
6,640 Added 9.83%
74,209 $2.03 Million
Q1 2022

May 13, 2022

BUY
$28.87 - $35.77 $422,021 - $522,885
14,618 Added 27.61%
67,569 $2.26 Million
Q4 2021

Feb 14, 2022

BUY
$29.25 - $36.02 $167,748 - $206,574
5,735 Added 12.15%
52,951 $1.84 Million
Q3 2021

Nov 12, 2021

SELL
$31.2 - $38.5 $75,566 - $93,247
-2,422 Reduced 4.88%
47,216 $1.47 Million
Q2 2021

Aug 13, 2021

BUY
$36.37 - $45.72 $1.81 Million - $2.27 Million
49,638 New
49,638 $1.81 Million

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $926M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.